HomeTRAW • NASDAQ
Traws Pharma Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.73M | 4,694.74% |
Operating expense | 3.98M | -32.97% |
Net income | -915.00K | 99.26% |
Net profit margin | -33.48 | 99.98% |
Earnings per share | — | — |
EBITDA | -1.25M | 78.78% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.08M | -22.53% |
Total assets | 15.62M | -16.40% |
Total liabilities | 7.36M | -41.53% |
Total equity | 8.26M | — |
Shares outstanding | 7.06M | — |
Price to book | 1.63 | — |
Return on assets | -18.00% | — |
Return on capital | -43.79% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -915.00K | 99.26% |
Cash from operations | -5.98M | 39.31% |
Cash from investing | — | — |
Cash from financing | 3.10M | -77.89% |
Net change in cash | -2.86M | -675.81% |
Free cash flow | -3.09M | -9.41% |
Previous close
$1.91
Day range
$1.85 - $1.96
Year range
$0.97 - $19.44
Market cap
13.24M USD
Avg Volume
146.63K
P/E ratio
0.09
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1998
Website
Employees
7
